Reducing relapse through maintenance steroid treatment can decrease the cancer risk in patients with IgG4-sclerosing cholangitis : based on a Japanese nationwide study.

Kensuke KubotaTerumi KamisawaTakahiro NakazawaAtsushi Tanaka Itaru NaitohYusuke KuritaHajime TakikawaMichiaki UnnoShigeyuki KawaAtsushi MasamuneSeiji NakamuraKazuichi Okazakinull null

Published in: Journal of gastroenterology and hepatology (2022)

Among the cancers, the risk of pancreatic and biliary cancers is the highest in these patients. Because of the elevated cancer risk, surveillance after the diagnosis and management to prevent relapse are important in patients with IgG4-SC to reduce the risk of development of cancer.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
public health
peritoneal dialysis
free survival
patient reported outcomes
combination therapy
ulcerative colitis